Good morning, everyone, and how are you today? A sunny morning is unfolding over the Pharmalot corporate campus, where we are ahead of schedule in depositing the short people at the local schoolhouses. To celebrate, yes, we are downing a much-needed cup of stimulation. And this is a needed jolt, because there is much to do today as we brace for meetings, deadlines and piles of documents. We know you relate. So here are a few tidibits to help you along. Have a great day...
BioCryst Gout Drug Helps Patients In Trial (Bloomberg News)
NABI Reviews Options After Anti-Smoking Vaccine Fails Trial (Bloomberg News)
Allergan Gets $17M Grant To Build NJ Plant And Add 400 Jobs (Wall Street Journal)
Amgen Plans To Buyback $5 Billion In Stock (Bloomberg News)
Teva Must Pay Pfizer Court Fees In Viagra Patent Fight (Courthouse News)
FDA Approves Wider Use Of Erbitux (Pharma Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning